Covidien to repurchase $3B more in company shares

03/25/2013 | Clinica (subscription required)

A plan by Covidien to buy back $3 billion of its stock has been approved by the company's board, a move expected to benefit shareholders over the short term. In August 2011, the company also initiated a similar repurchase program, worth $2 billion.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA